Vascular smooth muscle cell proliferation as a therapeutic target. Part 1: molecular targets and pathways
- PMID: 29684502
- DOI: 10.1016/j.biotechadv.2018.04.006
Vascular smooth muscle cell proliferation as a therapeutic target. Part 1: molecular targets and pathways
Abstract
Cardiovascular diseases are a major cause of human death worldwide. Excessive proliferation of vascular smooth muscle cells contributes to the etiology of such diseases, including atherosclerosis, restenosis, and pulmonary hypertension. The control of vascular cell proliferation is complex and encompasses interactions of many regulatory molecules and signaling pathways. Herein, we recapitulated the importance of signaling cascades relevant for the regulation of vascular cell proliferation. Detailed understanding of the mechanism underlying this process is essential for the identification of new lead compounds (e.g., natural products) for vascular therapies.
Keywords: Atherosclerosis; Cardiovascular diseases; Cell cycle; Proliferation; Pulmonary hypertension; Restenosis; Signaling pathway; Vascular smooth muscle cells.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Vascular smooth muscle cell proliferation as a therapeutic target. Part 2: Natural products inhibiting proliferation.Biotechnol Adv. 2018 Nov 1;36(6):1608-1621. doi: 10.1016/j.biotechadv.2018.04.002. Epub 2018 Apr 17. Biotechnol Adv. 2018. PMID: 29678389 Review.
-
IP-10/CXCR3 Axis Promotes the Proliferation of Vascular Smooth Muscle Cells through ERK1/2/CREB Signaling Pathway.Cell Biochem Biophys. 2017 Mar;75(1):139-147. doi: 10.1007/s12013-017-0782-9. Epub 2017 Jan 23. Cell Biochem Biophys. 2017. PMID: 28111710
-
7-cyclopentyl-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d] pyrimidin-4-ylamine inhibits the proliferation and migration of vascular smooth muscle cells by suppressing ERK and Akt pathways.Eur J Pharmacol. 2017 Mar 5;798:35-42. doi: 10.1016/j.ejphar.2017.02.004. Epub 2017 Feb 6. Eur J Pharmacol. 2017. PMID: 28185804
-
Long Non-Coding RNA MEG3 Downregulation Triggers Human Pulmonary Artery Smooth Muscle Cell Proliferation and Migration via the p53 Signaling Pathway.Cell Physiol Biochem. 2017;42(6):2569-2581. doi: 10.1159/000480218. Epub 2017 Aug 23. Cell Physiol Biochem. 2017. PMID: 28848087
-
Cell cycle progression: new therapeutic target for vascular proliferative disease.Circulation. 1998 Jul 7;98(1):82-9. doi: 10.1161/01.cir.98.1.82. Circulation. 1998. PMID: 9665064 Review.
Cited by
-
Injury and Healing Response of Healthy Peripheral Arterial Tissue to Intravascular Lithotripsy: A Prospective Animal Study.Front Cardiovasc Med. 2022 Mar 28;9:787973. doi: 10.3389/fcvm.2022.787973. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35419438 Free PMC article.
-
Pleiotropic Activity of Metformin and Its Sulfonamide Derivatives on Vascular and Platelet Haemostasis.Molecules. 2019 Dec 28;25(1):125. doi: 10.3390/molecules25010125. Molecules. 2019. PMID: 31905674 Free PMC article.
-
Resveratrol and Vascular Function.Int J Mol Sci. 2019 Apr 30;20(9):2155. doi: 10.3390/ijms20092155. Int J Mol Sci. 2019. PMID: 31052341 Free PMC article. Review.
-
Therapeutic Effects of Traditional Chinese Medicine on Cardiovascular Diseases: the Central Role of Calcium Signaling.Front Pharmacol. 2021 Jul 9;12:682273. doi: 10.3389/fphar.2021.682273. eCollection 2021. Front Pharmacol. 2021. PMID: 34305595 Free PMC article. Review.
-
A Lifelike guided journey through the pathophysiology of pulmonary hypertension-from measured metabolites to the mechanism of action of drugs.Front Cardiovasc Med. 2024 May 23;11:1341145. doi: 10.3389/fcvm.2024.1341145. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38845688 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources